Matthew Gubin, PhD, postdoctoral research scholar in the laboratory of Robert Schreiber, PhD, Alumni Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has received a three-year, $164,500 grant from the Cancer Research Institute for research titled “Using Genomics to Identify Targets of Checkpoint Blockade Cancer Treatment and Identify Optimal Target Antigens for Vaccination.”
Latest from the Record
Announcements
Advisory committee leads way on inclusive excellence, welcomes input
Flags lowered in memory of Charlie Kirk
Bauer Leaders Academy opens grant applications, hosts breakfast
Notables
Johnson named director of Division of Urologic Surgery
Advancement’s Martin selected for Focus St. Louis program
Guan named Earl E. and Myrtle E. Walker Professor of Engineering
Obituaries
Obituary: Stuart A. Kornfeld, professor emeritus of medicine, 88